Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis

Grymonprez, M; De Backer, TL; Steurbaut, S; Boussery, K; Lahousse, L

Grymonprez, M (通讯作者),Univ Ghent, Fac Pharmaceut Sci, Pharmaceut Care Unit, Dept Bioanal, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.

CARDIOVASCULAR DRUGS AND THERAPY, 2022; 36 (4): 749

Abstract

Purpose Oral anticoagulants are crucial for preventing systemic thromboembolism in atrial fibrillation (AF), with guidelines preferring non-vitamin K ......

Full Text Link